
How much is a share of Labu worth?
One share of LABU stock can currently be purchased for approximately $27.38. How much money does Direxion Daily S&P Biotech Bull 3x Shares make? Direxion Daily S&P Biotech Bull 3x Shares has a market capitalization of $891.55 million.
Is Labu a sell or buy on Robinhood?
Today LABU ranks #9734 as sell candidate. Get a Free Stock at Robinhood Which way will LABU go? This ETF may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this ETF is considered to be "very high risk".
How doeslabu work?
LABU is a daily 3x leveraged bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment.
Which way will Labu go?
Which way will LABU go? This ETF may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this ETF is considered to be "very high risk". During the last day, the ETF moved $0.99 between high and low, or 6.88%.
Is Labu a buy?
It is not often that an investor gets to buy superb companies at rock-bottom prices, and in a burgeoning growth sector too. The Direxion Biotechnology ETF (NYSEARCA:LABU) is now such an opportunity....Summary.(LABU)January 25, 2022 (intraday)$18-92%3 more rows•Jan 26, 2022
What is Direxion Daily S&P Biotech Bull 3X Shares ETF?
The Direxion Daily S&P Biotech Bull 3X Fund (LABU) is an ETF that seeks to replicate 300% of the daily performance of its benchmark, the S&P Biotechnology Select Industry Index. The fund invests primarily in swap agreements and futures contracts that provide daily leveraged exposure to the benchmark index.
What companies are in Labu?
Top 10 HoldingsCompanySymbolTotal Net AssetsDreyfus Government Cash Management Institutional ShsDGCXX25.31%Financial Square Treasury Instruments Fund FST SharesFTIXX18.59%Financial Square Government Fund FST SharesFGTXX6.51%United Therapeutics Corp.UTHR0.89%6 more rows
What are 3x Shares?
An ETF that is leveraged 3x seeks to return three times the return of the index or other benchmark that it tracks. A 3x S&P 500 index ETF, for instance, would return +3% if the S&P rose by 1%. It would also lose 3% if the S&P dropped by 1%.
What is TECL stock?
TECL - Direxion Daily Technology Bull 3X SharesPrevious Close29.91Day's Range30.41 - 31.5252 Week Range25.14 - 91.04Volume3,865,195Avg. Volume5,006,6193 more rows
What stocks are in cure ETF?
Top 10 Holdings (66.27% of Total Assets)NameSymbol% AssetsAbbott LaboratoriesABT2.58%AbbVie IncABBV2.49%Thermo Fisher Scientific IncTMO2.48%Merck & Co IncMRK2.47%6 more rows
What is the Nasdaq Biotechnology Index?
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. A list of the 213 components of the index is published online.
What stocks does Soxl?
Top 10 HoldingsCompanySymbolTotal Net AssetsAdvanced Micro Devices Inc.AMD4.42%NVIDIA Corp.NVDA4.10%Intel Corp.INTC3.72%Qualcomm Inc.QCOM3.33%6 more rows
How has Direxion Daily S&P Biotech Bull 3x Shares' stock performed in 2022?
Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $36.00 at the start of the year. Since then, LABU shares have decreased by 85.5% an...
What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bull 3x Shares investors own inc...
What is Direxion Daily S&P Biotech Bull 3x Shares' stock symbol?
Direxion Daily S&P Biotech Bull 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABU."
Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders?
Direxion Daily S&P Biotech Bull 3x Shares' stock is owned by many different retail and institutional investors. Top institutional shareholders incl...
Which major investors are selling Direxion Daily S&P Biotech Bull 3x Shares stock?
LABU stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP, Jane Street Group LLC, HAP Trading LLC,...
Which major investors are buying Direxion Daily S&P Biotech Bull 3x Shares stock?
LABU stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Traynor Capital Manag...
How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares?
Shares of LABU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Direxion Daily S&P Biotech Bull 3x Shares' stock price today?
One share of LABU stock can currently be purchased for approximately $5.23.
How much money does Direxion Daily S&P Biotech Bull 3x Shares make?
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) has a market capitalization of $432.57 million.
How has Direxion Daily S&P Biotech Bull 3x Shares' stock been impacted by Coronavirus (COVID-19)?
Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $30.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LABU shares have decreased by 45.0% and is now trading at $16.52. View which stocks have been most impacted by COVID-19.
What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), NVIDIA (NVDA), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Alibaba Group (BABA), ProShares UltraPro QQQ (TQQQ), Advanced Micro Devices (AMD), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Boeing (BA), (CGC) and Gilead Sciences (GILD)..
What is Direxion Daily S&P Biotech Bull 3x Shares' stock symbol?
Direxion Daily S&P Biotech Bull 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LABU."
Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders?
Direxion Daily S&P Biotech Bull 3x Shares' stock is owned by many different retail and institutional investors.
Which major investors are selling Direxion Daily S&P Biotech Bull 3x Shares stock?
LABU stock was sold by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, and Parallax Volatility Advisers L.P..
Which major investors are buying Direxion Daily S&P Biotech Bull 3x Shares stock?
LABU stock was bought by a variety of institutional investors in the last quarter, including Cutler Group LP, Citadel Advisors LLC, Wolverine Trading LLC, Requisite Capital Management LLC, Traynor Capital Management Inc., Squarepoint Ops LLC, Hellman Jordan Management Co. Inc. MA, and JBF Capital Inc..
How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares?
Shares of LABU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
5 Best Leveraged ETFs of Last Week
The S&P 500 hit to record close last week, as investors gained optimism from some of President Joe Biden's encouraging announcements regarding booster shots and testing kits.
Biotech Belonged to the Bears in Second Half of 2021
A bearish sentiment in biotechnology took over in the second half of 2021, providing gains for the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed almost 21% in the second half of 2021, g...
Omicron Variant Is Boosting This Leveraged Biotech ETF
The Omicron variant re-asserted the strength of biotech equities, making the Direxion Daily S&P Biotech Bull 3x Shares (LABU) an option for traders. As investors turned up the risk dial, COVID-19 cases ...
Best Leveraged ETF Areas of Last Week
Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
5 Best-Performing Leveraged ETFs of August
The MSCI's broadest index of world stocks on its best run of monthly gains since 2017-2018.
7 Best Leveraged ETF Areas of Last Week
Wall Street was upbeat last week. News of zero new cases in China, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine and no new flare-up in taper talks led to the gains.
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
Signals & Forecast
There are mixed signals in the ETF today. The Direxion Daily S&P Biotech Bull 3X ETF holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Support, Risk & Stop-loss
On the downside, the ETF finds support just below today's level from accumulated volume at $15.18. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0 may give a huge drop in the ETF price.
Is Direxion Daily S&P Biotech Bull 3X ETF ETF A Buy?
Direxion Daily S&P Biotech Bull 3X holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this ETF.
